Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI2004

Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.

T A Hentunen, S V Reddy, B F Boyce, R Devlin, H R Park, H Chung, K S Selander, M Dallas, N Kurihara, D L Galson, S R Goldring, B A Koop, J J Windle, and G D Roodman

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Hentunen, T. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Reddy, S. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Boyce, B. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Devlin, R. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Park, H. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Chung, H. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Selander, K. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Dallas, M. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Kurihara, N. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Galson, D. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Goldring, S. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Koop, B. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Windle, J. in: PubMed | Google Scholar

Department of Medicine/Hematology, San Antonio, Texas 78284, USA.

Find articles by Roodman, G. in: PubMed | Google Scholar

Published July 1, 1998 - More info

Published in Volume 102, Issue 1 on July 1, 1998
J Clin Invest. 1998;102(1):88–97. https://doi.org/10.1172/JCI2004.
© 1998 The American Society for Clinical Investigation
Published July 1, 1998 - Version history
View PDF
Abstract

Cellular and molecular characterization of osteoclasts (OCL) has been extremely difficult since OCL are rare cells, and are difficult to isolate in large numbers. We used the tartrate-resistant acid phosphatase promoter to target the bcl-XL and/or Simian Virus 40 large T antigen (Tag) genes to cells in the OCL lineage in transgenic mice as a means of immortalizing OCL precursors. Immunocytochemical studies confirmed that we had targeted Bcl-XL and/or Tag to OCL, and transformed and mitotic OCL were readily apparent in bones from both Tag and bcl-XL/Tag mice. OCL formation in primary bone marrow cultures from bcl-XL, Tag, or bcl-XL/Tag mice was twofold greater compared with that of nontransgenic littermates. Bone marrow cells from bcl-XL/Tag mice, but not from singly transgenic bcl-XL or Tag mice, have survived in continuous culture for more than a year. These cells form high numbers of bone-resorbing OCL when cultured using standard conditions for inducing OCL formation, with approximately 50% of the mononuclear cells incorporated into OCL. The OCL that form express calcitonin receptors and contract in response to calcitonin. Studies examining the proliferative capacity and the resistance of OCL precursors from these transgenic mice to apoptosis demonstrated that the increased numbers of OCL precursors in marrow from bcl-XL/Tag mice was due to their increased survival rather than an increased proliferative capacity compared with Tag, bcl-XL, or normal mice. Histomorphometric studies of bones from bcl-XL/Tag mice also confirmed that there were increased numbers of OCL precursors (TRAP + mononuclear cells) present in vivo. These data demonstrate that by targeting both bcl-XL and Tag to cells in the OCL lineage, we have immortalized OCL precursors that form bone-resorbing OCL with an efficiency that is 300-500 times greater than that of normal marrow.

Version history
  • Version 1 (July 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts